Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.12 USD | +3.23% | +32.25% | +18.98% |
Apr. 16 | Leerink Partners Starts AnaptysBio With Outperform Rating, $47 Price Target | MT |
Apr. 11 | Wells Fargo Initiates AnaptysBio With Overweight Rating, $56 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.98% | 665M | |
-3.10% | 102B | |
+1.46% | 96.09B | |
+2.13% | 22.28B | |
-17.21% | 21.4B | |
-8.93% | 18.14B | |
-39.98% | 17.02B | |
-14.29% | 16.09B | |
+7.88% | 13.83B | |
+33.03% | 11.97B |
- Stock Market
- Equities
- ANAB Stock
- News AnaptysBio, Inc.
- HC Wainwright Assumes AnaptysBio at Buy with $35 Price Target